Quality of life, infection control, and complication rates using a novel custom-made articulating hip spacer during two-stage revision for periprosthetic joint infection

• Verfasst von: Lunz, André [VerfasserIn]
• Verfasst von: Omlor, Georg [VerfasserIn]
• Verfasst von: Schmidt, Gunter [VerfasserIn]
• Verfasst von: Moradi, Babak [VerfasserIn]
• Verfasst von: Lehner, Burkhard [VerfasserIn]
• Verfasst von: Streit, Marcus R. [VerfasserIn]
• Titel: Quality of life, infection control, and complication rates using a novel custom-made articulating hip spacer during two-stage revision for periprosthetic joint infection
• Verf.angabe: Andre Lunz, Georg W. Omlor, Gunter Schmidt, Babak Moradi, Burkhard Lehner & Marcus R.Streit
• Jahr: 2022
• Umfang: 14 S.
• Fussnoten: Online veröffentlicht: 1.Dezember 2021 ; Gesehen am 03.07.2023
• Titel Quelle: Enthalten in: Archives of orthopaedic and trauma surgery
• Ort Quelle: Berlin : Springer, 1903
• Jahr Quelle: 2022
• Band/Heft Quelle: 142(2022), 12, Seite 4041-4054
• ISSN Quelle: 1434-3916
• DOI: doi:10.1007/s00402-021-04274-4
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1851389008
• K10plus-PPN:
  Universitätsbibliothek
• Lokale URL UB: Zum Volltext

Abstract

Introduction  Two-stage revision remains the gold standard treatment for most chronically infected and complex total hip arthroplasty infections. To improve patient outcome and reduce complication rates, we have developed a novel custom-made articulating hip spacer technique and present our short-term results. Materials and methods  Between November 2017 and November 2019, 27 patients (mean age 70 years) underwent two-stage revision for periprosthetic joint infection of the hip using the articulating spacer design described here. We retrospectively analyzed spacer-related complications as well as rates for complication, infection control, and implant survivorship after final reimplantation. Furthermore, we prospectively collected patient-reported health-related quality of life (HRQoL) scores prior to spacer implantation, with the spacer and after reimplantation of the new prosthesis. - Results  An additional round of spacer exchange was performed in two patients (8.3%), persistent wound discharge was the reason in both cases. We had one (4.2%) spacer-related mechanical complication, a dislocation that was treated with closed reduction. After reimplantation, infection control was achieved in 96% with an implant survivorship of 92% after a mean follow-up time of 19 (range 7-32, SD 7.2) months. While the scores for VR-12 MCS, VAS hip pain and patient-reported overall satisfaction significantly improved after first stage surgery, the scores for WOMAC, UCLA and VR-12 PCS significantly improved after second stage surgery. - Conclusions  Our two-stage approach for periprosthetic joint infection shows high infection eradication and implant survivorship rates at short-term follow-up. Spacer-related complication rates were low, and we achieved high patient satisfaction rates and low pain levels already during the spacer period. To further simplify comparison between different spacer designs, we propose a new hip spacer classification system.